Anti-angiogenic therapy for persistent, recurrent and metastatic cervical cancer

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effectiveness and safety of angiogenesis inhibitors in the management of persistent, recurrent and metastatic cervical cancer.